These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6099733)

  • 1. Enalapril in heart failure.
    Nicholls MG; Ikram H; Espiner EA; Webster MW; Fitzpatrick MA
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):163S-167S. PubMed ID: 6099733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B; Cubela R; Johnston CI
    J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enalapril for severe congestive heart failure. A double-blind study.
    Jennings G; Kiat H; Nelson L; Kelly MJ; Kalff V; Johns J
    Med J Aust; 1984 Nov; 141(11):723-6. PubMed ID: 6094995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled trial of enalapril in congestive cardiac failure.
    McGrath BP; Arnolda L; Matthews PG; Jackson B; Jennings G; Kiat H; Johnston CI
    Br Heart J; 1985 Oct; 54(4):405-14. PubMed ID: 2996575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A
    Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ; Lees KR; Reid JL
    Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of enalapril, a new converting enzyme inhibitor, in hypertension.
    Ferguson RK; Vlasses PH; Swanson BN; Mojaverian P; Hichens M; Irvin JD; Huber PB
    Clin Pharmacol Ther; 1982 Jul; 32(1):48-53. PubMed ID: 6282527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure.
    Fitzpatrick D; Nicholls MG; Ikram H; Espiner EA
    Br Heart J; 1983 Aug; 50(2):163-9. PubMed ID: 6309203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.
    Cleland JG; Dargie HJ; Ball SG; Gillen G; Hodsman GP; Morton JJ; East BW; Robertson I; Ford I; Robertson JI
    Br Heart J; 1985 Sep; 54(3):305-12. PubMed ID: 2994698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.
    Sharpe DN; Murphy J; Coxon R; Hannan SF
    Circulation; 1984 Aug; 70(2):271-8. PubMed ID: 6329547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure.
    Franciosa JA; Wilen MM; Jordan RA
    J Am Coll Cardiol; 1985 Jan; 5(1):101-7. PubMed ID: 2981088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful management of severe congestive cardiac failure with enalapril.
    Dickstein K; Gundersen T
    Am J Med; 1983 Oct; 75(4):721-3. PubMed ID: 6312795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of angiotensin-converting enzyme gene polymorphism on neurohormonal responses to high- versus low-dose enalapril in advanced heart failure.
    Tang WH; Vagelos RH; Yee YG; Fowler MB
    Am Heart J; 2004 Nov; 148(5):889-94. PubMed ID: 15523323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of antihypertensive effect of enalapril to serum MK-422 levels and angiotensin converting enzyme inhibition.
    Johnston CI; Jackson B; McGrath B; Matthews G; Arnolda L
    J Hypertens Suppl; 1983 Oct; 1(1):71-5. PubMed ID: 6100611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure.
    Creager MA; Massie BM; Faxon DP; Friedman SD; Kramer BL; Weiner DA; Ryan TJ; Topic N; Melidossian CD
    J Am Coll Cardiol; 1985 Jul; 6(1):163-73. PubMed ID: 2989349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue angiotensin converting enzyme inhibition as an index of the disposition of enalapril (MK-421) and metabolite MK-422.
    Cohen ML; Kurz KD; Schenck KW
    J Pharmacol Exp Ther; 1983 Jul; 226(1):192-6. PubMed ID: 6306224
    [No Abstract]   [Full Text] [Related]  

  • 18. Combining salicylate and enalapril in patients with coronary artery disease and heart failure.
    Baur LH; Schipperheyn JJ; van der Laarse A; Souverijn JH; Frölich M; de Groot A; Voogd PJ; Vroom TF; Cats VM; Keirse MJ
    Br Heart J; 1995 Mar; 73(3):227-36. PubMed ID: 7727181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and long-term response to enalapril in congestive failure.
    Kjekshus JK; Søyland E; Dickstein K; Abrahamsen AM; Gundersen T
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):169S-174S. PubMed ID: 6099734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double blind controlled study of low dose intravenous perindoprilat or enalaprilat infusion in elderly patients with heart failure.
    MacFadyen RJ; Lees KR; Reid JL
    Br Heart J; 1993 Apr; 69(4):293-7. PubMed ID: 8387806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.